Chee Kin Hui

Summary

Publications

  1. pmc Pegylated interferon alpha-2a (40 kDa) in the treatment of chronic hepatitis B
    Lawrence Lai
    Department of Medicine, Caritas Medical Centre, Hong Kong SAR, China
    Int J Nanomedicine 1:255-62. 2006
  2. ncbi request reprint Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection
    Chee Kin Hui
    Department of Medicine, The University of Hong Kong, Hong Kong SAR, China
    J Clin Virol 35:185-92. 2006
  3. ncbi request reprint 48 weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon alpha-2b in achieving hepatitis B e antigen seroconversion in chronic hepatitis B infection
    C K Hui
    Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    Aliment Pharmacol Ther 23:1171-8. 2006
  4. ncbi request reprint Natural history of patients with recurrent chronic hepatitis C virus and occult hepatitis B co-infection after liver transplantation
    C K Hui
    Department of Medicine, The University of Hong Kong, Hong Kong SAR, China
    Am J Transplant 6:1600-8. 2006
  5. ncbi request reprint Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy
    Chee Kin Hui
    Centre For The Study of Liver Diseases, The University of Hong Kong, Hong Kong SAR, China
    Gastroenterology 131:59-68. 2006
  6. ncbi request reprint Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B
    Chee Kin Hui
    Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    J Hepatol 47:191-202. 2007
  7. ncbi request reprint Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase
    Chee Kin Hui
    Department of Medicine, University of Hong Kong, Hong Kong Special Administrative Region SAR, China
    Hepatology 46:395-401. 2007
  8. ncbi request reprint Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients
    Chee Kin Hui
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong Special Administrative Region SAR, China
    Hepatology 46:690-8. 2007
  9. doi request reprint Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications
    Chee Kin Hui
    Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China
    J Clin Gastroenterol 42:533-8. 2008
  10. pmc Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy
    C K Hui
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Rd, Hong Kong SAR, China
    Gut 54:1597-603. 2005

Detail Information

Publications54

  1. pmc Pegylated interferon alpha-2a (40 kDa) in the treatment of chronic hepatitis B
    Lawrence Lai
    Department of Medicine, Caritas Medical Centre, Hong Kong SAR, China
    Int J Nanomedicine 1:255-62. 2006
    ..These recent data put pegylated interferon alpha-2a as the first choice of anti-HBV therapy, especially in young and motivated patients with chronic HBV infection...
  2. ncbi request reprint Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection
    Chee Kin Hui
    Department of Medicine, The University of Hong Kong, Hong Kong SAR, China
    J Clin Virol 35:185-92. 2006
    ..946). In conclusion, chronic HCV patients with occult HBV co-infection does not seem to progress more than patients without occult HBV infection. However, more large-scale studies are needed before a definite conclusion can be obtained...
  3. ncbi request reprint 48 weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon alpha-2b in achieving hepatitis B e antigen seroconversion in chronic hepatitis B infection
    C K Hui
    Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    Aliment Pharmacol Ther 23:1171-8. 2006
    ..Although 48-week therapy with pegylated-interferons has been shown to be effective for the treatment of chronic hepatitis B virus infection, the efficacy of a shorter duration of therapy with pegylated interferons is unknown...
  4. ncbi request reprint Natural history of patients with recurrent chronic hepatitis C virus and occult hepatitis B co-infection after liver transplantation
    C K Hui
    Department of Medicine, The University of Hong Kong, Hong Kong SAR, China
    Am J Transplant 6:1600-8. 2006
    ..97). In conclusion, occult hepatitis B virus co-infection in patients with recurrent chronic hepatitis C infection was not associated with accelerated fibrosis progression or severe fibrosis after liver transplantation...
  5. ncbi request reprint Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy
    Chee Kin Hui
    Centre For The Study of Liver Diseases, The University of Hong Kong, Hong Kong SAR, China
    Gastroenterology 131:59-68. 2006
    ..De novo hepatitis B virus (HBV)-related hepatitis after chemotherapy results in high morbidity and mortality. We evaluate the clinical course of de novo HBV-related hepatitis after chemotherapy...
  6. ncbi request reprint Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B
    Chee Kin Hui
    Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    J Hepatol 47:191-202. 2007
    ..We studied the role of adiponectin in 2 chronic hepatitis B (CHB)-patient cohorts...
  7. ncbi request reprint Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase
    Chee Kin Hui
    Department of Medicine, University of Hong Kong, Hong Kong Special Administrative Region SAR, China
    Hepatology 46:395-401. 2007
    ..40-0.20 U/year] versus 0.21 U/year [range 0-1.11 U/year], respectively, P = 0.04)...
  8. ncbi request reprint Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients
    Chee Kin Hui
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong Special Administrative Region SAR, China
    Hepatology 46:690-8. 2007
    ..00 to -0.70 fibrosis units/year, versus median 0.51 fibrosis units/year, range 0 to +2.03 fibrosis units/year, P = 0.02)...
  9. doi request reprint Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications
    Chee Kin Hui
    Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China
    J Clin Gastroenterol 42:533-8. 2008
    ..Improvement in modified HAI after antiviral therapy has usually been defined as a 2-point reduction in modified HAI score...
  10. pmc Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy
    C K Hui
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Rd, Hong Kong SAR, China
    Gut 54:1597-603. 2005
    ..The hepatic outcome of hepatitis B surface antigen (HBsAg) positive patients undergoing chemotherapy after withdrawal of pre-emptive lamivudine is unknown...
  11. ncbi request reprint Sexual transmission of hepatitis B infection despite the presence of hepatitis B virus immunity in recipients of allogeneic bone marrow transplantation
    Chee Kin Hui
    Division of Gastroenterology and Hepatology, University Department of Medicine, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, SAR, China
    J Clin Virol 32:173-8. 2005
    ..After hematopoietic cell transplantation (HCT), hepatitis due to hepatitis B virus (HBV) rarely occurred beyond the initial 12 months after transplantation...
  12. ncbi request reprint A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation
    Chee Kin Hui
    Division of Gastroenterology and Hepatology, The University of Hong Kong, SAR, China
    Blood 106:464-9. 2005
    ..Our study showed that long-term hepatic complications occur in a significant proportion of HBsAg+ patients after HSCT and the incidence of liver cirrhosis is reduced in those with sustained serologic clearance of HBsAg after HSCT...
  13. ncbi request reprint Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B
    George K K Lau
    Department of Medicine, Queen Mary Hospital, Hong Kong SAR, China
    Antivir Ther 12:705-18. 2007
    ..The patterns of hepatitis B viral dynamics during different antiviral therapies and the associated changes in HBV-specific T-cell reactivity are not well defined...
  14. ncbi request reprint Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine
    Man Fung Yuen
    Division of Gastroenterology and Hepatology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong
    Antivir Ther 8:531-4. 2003
    ..Determination of HBV genotypes before lamivudine therapy was probably not an important pretreatment investigation to predict antiviral responses in Chinese patients...
  15. ncbi request reprint Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients
    Wai Man Wong
    Department of Medicine, Queen Mary Hospital, University of Hong Kong, Pokfulam Road, Hong Kong
    J Gastroenterol Hepatol 20:935-40. 2005
    ..The effects were compared of 7-day low-dose and high dose rabeprazole in RAM for the primary treatment of H. pylori infection in Chinese patients...
  16. ncbi request reprint Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma
    Man Fung Yuen
    Division of Gastroenterology and Hepatology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China
    Hepatology 37:562-7. 2003
    ..Genotypes B and C are associated with high prevalence of precore and core promoter mutations, respectively...
  17. ncbi request reprint Prognostic factors in severe exacerbation of chronic hepatitis B
    Man Fung Yuen
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China
    Clin Infect Dis 36:979-84. 2003
    ..3%; P=.004). Patients with severe exacerbation of hepatitis B with poor prognostic factors should be considered for early liver transplantation...
  18. ncbi request reprint Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus
    Man Fung Yuen
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, People s Republic of China
    J Infect Dis 186:1335-8. 2002
    ..The development of complications was not related to precore mutations but was probably due to the persistence of significant viremia after HBeAg seroconversion...
  19. ncbi request reprint Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: a comparison with genotype 1
    Chee Kin Hui
    Department of Medicine, Queen Mary Hospital, The University of Hong Kong, 102 Pokfulam Road, Hong Kong, China
    J Infect Dis 187:1071-4. 2003
    ..05). A sustained virological response (SVR) was present in 10 (62.5%) patients with genotype 6 and in 7 (29.2%) patients with genotype 1 (P=.04). Genotype 6 has a better response than genotype 1 and is associated with a higher SVR...
  20. ncbi request reprint Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area
    Chee Kin Hui
    Department of Medicine, Queen Mary Hospital, The University of Hong Kong, 102 Pokfulam Road, Hong Kong SAR, China
    J Hepatol 42:813-9. 2005
    ..The aim of this study is to determine the prevalence of occult HBV in allogeneic hematopoietic stem cell (HSC) transplantation donors...
  21. pmc Detection of intrahepatic hepatitis B virus DNA and correlation with hepatic necroinflammation and fibrosis
    Danny Ka Ho Wong
    Division of Gastroenterology and Hepatology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam Rd, Hong Kong, China
    J Clin Microbiol 42:3920-4. 2004
    ..842; P < 0.001) and with the degree of fibrosis (P = 0.014). We conclude that the method that we describe is reliable and convenient for the measurement of intrahepatic HBV DNA levels and has potential clinical significance...
  22. pmc Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapy
    Chee Kin Hui
    Department of Medicine, University of Hong Kong, Hong Kong, SAR, China
    J Clin Microbiol 44:2983-7. 2006
    ..The results of the RealART and Digene Hybrid assays were related (r = 0.94; P < 0.001) and diverged by 2 orders of magnitude. The RealART assay can be used to effectively monitor serum hepatitis B virus DNA levels...
  23. ncbi request reprint Effectiveness of prophylactic Anti-HBV therapy in allogeneic hematopoietic stem cell transplantation with HBsAg positive donors
    Chee Kin Hui
    Division of Gastroenterology and Hepatology, The University of Hong Kong, China
    Am J Transplant 5:1437-45. 2005
    ..01, adjusted hazards ratio 7.27, 95%CI 1.62-32.58). Our data support the use of prophylactic therapy in preventing HBV-related hepatitis after allogeneic HSCT from HBsAg-positive donor...
  24. ncbi request reprint Cholangiocarcinoma in liver cirrhosis
    Chee Kin Hui
    Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China
    J Gastroenterol Hepatol 18:337-41. 2003
    ..The purpose of the present study was to evaluate CC in liver cirrhosis...
  25. ncbi request reprint Outpatients undergoing therapeutic endoscopic retrograde cholangiopancreatography: six-hour versus overnight observation
    Chee Kin Hui
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong
    J Gastroenterol Hepatol 19:1163-8. 2004
    ....
  26. ncbi request reprint Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy
    Ching Lung Lai
    Department of Medicine, Queen Mary Hospital, Hong Kong
    J Med Virol 67:334-8. 2002
    ..It was concluded that in Chinese patients with chronic hepatitis B infection, lamivudine achieved effective suppression of HBV DNA levels within 4 weeks of therapy whereas famciclovir had a significantly weaker action...
  27. doi request reprint 96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B
    Chee Kin Hui
    Department of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    J Hepatol 48:714-20. 2008
    ..To determine the efficacy of adefovir dipivoxil (ADV) plus emtricitabine (FTC) combination therapy in chronic HBV infection...
  28. ncbi request reprint A pilot study of transcatheter arterial interferon embolization for patients with hepatocellular carcinoma
    Man Fung Yuen
    Department of Medicine, The University of Hong Kong, Queen Mary Hospital, USA
    Cancer 97:2776-82. 2003
    ..The objective of the current study was to determine the efficacy and safety of transcatheter arterial interferon embolization for the treatment of patients with inoperable HCC...
  29. ncbi request reprint A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma
    Annie O Chan
    Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong
    Cancer 94:1747-52. 2002
    ..Transcatheter intraarterial lipiodol chemoembolization (TACE) has been reported to be one of the most effective palliative measures for HCC. However, its severe side effects continue to make its use controversial...
  30. ncbi request reprint Recombinant interferon alfa 2b therapy in a patient with metastatic hepatocellular carcinoma
    Man Fung Yuen
    Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong
    J Clin Gastroenterol 35:272-5. 2002
    ..The time for its administration can also serve as an observation period, which is vital in deciding whether definitive surgical treatment of any residual lesions is indicated...
  31. ncbi request reprint Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients
    Danny Ka Ho Wong
    Division of Gastroenterology and Hepatology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China
    Hepatology 40:727-37. 2004
    ..Serum and intrahepatic total HBV DNA and cccDNA levels become lower as the disease progresses from HBeAg-positive to anti-HBe-positive phase, with cccDNA becoming the predominant form of intrahepatic HBV DNA...
  32. ncbi request reprint Peginterferon-alpha2a (40 kDa) (Pegasys) for hepatitis B
    Chee Kin Hui
    Department of Medicine, Center for the Study of Liver Diseases, University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong SAR, China
    Expert Rev Anti Infect Ther 3:495-504. 2005
    ....
  33. ncbi request reprint Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance
    Wai Man Wong
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China
    Clin Infect Dis 37:882-9. 2003
    ..MtxR and ClaR significantly affected the success of eradication therapy. Posttreatment rates of resistance were high and were related to the presence of pretreatment antibiotic resistance...
  34. ncbi request reprint Role of cholecystectomy in preventing recurrent cholangitis
    Chee Kin Hui
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China
    Gastrointest Endosc 56:55-60. 2002
    ..The purpose of this study was to analyze the role of elective cholecystectomy in preventing recurrent acute cholangitis in Asian patients...
  35. ncbi request reprint Silver nanoparticles inhibit hepatitis B virus replication
    Lei Lu
    Department of Medicine, The University of Hong Kong, Pokfulam Road, Hong Kong, China
    Antivir Ther 13:253-62. 2008
    ..The aim of the present study was to investigate the effects of silver nanoparticles on hepatitis B virus (HBV)...
  36. ncbi request reprint Mirtazapine-induced hepatotoxicity
    Chee Kin Hui
    Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China
    J Clin Gastroenterol 35:270-1. 2002
    ..The cause of mirtazapine-induced liver toxicity was unknown, and to our knowledge, these are the first reported cases of mirtazapine-induced prolonged jaundice...
  37. ncbi request reprint Current issues and future directions in treatment
    Chee Kin Hui
    Center for the Study of Liver Diseases, The University of Hong Kong, SAR, China
    Semin Liver Dis 26:192-7. 2006
    ..Further improvement in CHB therapy is limited by a lack of understanding of the host immune characteristics associated with sustained disease remission...
  38. ncbi request reprint Immune system and hepatitis B virus infection
    Chee Kin Hui
    Department of Medicine, The University of Hong Kong, Hong Kong SAR, China
    J Clin Virol 34:S44-8. 2005
    ..Therapeutic strategies aimed at correcting this defective T cell reactivity could represent a complementary approach to the cure of chronic HBV infection...
  39. ncbi request reprint Management of chronic hepatitis B in treatment-experienced patients
    Chee Kin Hui
    Division of Gastroenterology and Hepatology, University Department of Medicine, Queen Mary Hospital, 103 Pokfulam Road, Hong Kong SAR, China
    Gastroenterol Clin North Am 33:601-16, x. 2004
    ....
  40. doi request reprint Retracted: outcome and immune reconstitution of HBV-specific immunity in patients with reactivation of occult HBV infection after alemtuzumab-containing chemotherapy regimen
    Chee Kin Hui
    Department of Microbiology, University of Hong Kong, Queen Mary Hospital, Hong Kong, Special Administrative Region, China
    Hepatology 48:1-10. 2008
    ..Loss of HBsAg occurred after recovery of the CD4+T cell count and increased CD4+T cell reactivity against HBcAg 9 months after the end of chemotherapy...
  41. doi request reprint Prevalence and time trend of intestinal metaplasia in Hong Kong
    Yuk Kei Yee
    Department of Medicine, The University of Hong Kong, Hong Kong
    J Gastroenterol Hepatol 24:896-9. 2009
    ....
  42. ncbi request reprint Clevudine for the treatment of chronic hepatitis B virus infection
    Chee Kin Hui
    Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, China
    Expert Opin Investig Drugs 14:1277-84. 2005
    ..Based on the early results of clevudine, more large-scale human studies with clevudine monotherapy or combination therapy is eagerly awaited...
  43. doi request reprint Human metapneumovirus infection in an immunocompetent adult presenting as mononucleosis-like illness
    Iris W S Li
    Department of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong
    J Infect 56:389-92. 2008
    ..There was a >/=4-fold rise in IgG against hMPV. This is the first case report illustrating the natural clinical course of hMPV-related MLI...
  44. ncbi request reprint Tumor necrosis factor-alpha-induced protein 1 and immunity to hepatitis B virus
    Marie C Lin
    Department of Medicine, Queen Mary Hospital 102 Pokfulum Road, Hong Kong SAR, China
    World J Gastroenterol 11:7564-8. 2005
    ..To compare the gene expression profile in a pair of HBV-infected twins...
  45. ncbi request reprint Does the addition of endoscopic sphincterotomy to stent insertion improve drainage of the bile duct in acute suppurative cholangitis?
    Chee Kin Hui
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China
    Gastrointest Endosc 58:500-4. 2003
    ..The aim of this retrospective study was to determine whether endoscopic sphincterotomy, in addition to an internal endoprosthesis, improves outcome for patients with acute suppurative cholangitis...
  46. ncbi request reprint Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients
    Man Fung Yuen
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China
    Am J Gastroenterol 98:1181-5. 2003
    ..We conducted a comparative study to determine whether TACE treatment had any survival benefit for patients with unresectable hepatocellular carcinoma (HCC) and with relatively preserved liver function...
  47. ncbi request reprint Treatment of Hepatitis B e Antigen-negative Patients
    Chee Kin Hui
    George K Lau, MD, FRCP Department of Medicine, Room 1838, Block K, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong SAR, China
    Curr Treat Options Gastroenterol 10:474-82. 2007
    ..However, this latter approach can lead to development of viral resistance and long-term safety concerns...
  48. ncbi request reprint A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase
    Chee Kin Hui
    Department of Medicine, GI Research 111B, Veterans Affairs Medical Center, 4150 Clement Street, San Francisco, CA 94121, USA
    J Hepatol 38:511-7. 2003
    ..Detectable serum hepatitis C virus (HCV) RNA in HCV patients with persistently normal alanine transaminase (PNALT) has been found to be associated with significant liver damage...
  49. ncbi request reprint Oral arsenic trioxide therapy for acute promyelocytic leukemia before and after liver transplantation for hepatitis B virus-related liver failure
    Wing Yan Au
    Ann Hematol 86:771-2. 2007
  50. ncbi request reprint Clinical significance of intrahepatic hepatitis B virus covalently closed circular DNA in chronic hepatitis B patients who received cytotoxic chemotherapy
    Chee Kin Hui
    Blood 105:2616-7. 2005
  51. ncbi request reprint Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin
    Yangchao Chen
    Stanley Ho Center for Emerging Infectious Diseases, Hong Kong, China
    Hepatology 46:200-8. 2007
    ....
  52. ncbi request reprint Reversal of protein-losing enteropathy by liver transplantation
    Wai Man Wong
    J Clin Gastroenterol 36:86-7. 2003
  53. pmc Trends for genetic variation of Hepatitis C Virus quasispecies in Human Immunodeficiency virus-1 coinfected patients
    F Xavier López-Labrador
    Public Health Department, Generalitat Valenciana and Evolutionary Genetics Unit, Institut Cavanilles de Biodiversitat i Biologia Evolutiva, University of Valencia, Apt Of 2085, E 46071 Valencia, Spain
    Virus Res 130:285-91. 2007
    ..Differences in immune regulation of HCV quasispecies in HIV coinfected individuals deserve further exploration to clarify the different outcomes of chronic hepatitis C noted between the immunocompromised and the immunocompetent host...
  54. ncbi request reprint Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model
    John M Luk
    Centre for the Study of Liver Disease and Department of Surgery, The University of Hong Kong, Hong Kong
    Liver Int 27:548-57. 2007
    ....